Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats

Diabetes Research and Clinical Practice

Volumn 87, Issue 2, 2010, Pages 184-191

  Angelini, Nágela ^a   Rafacho, Alex ^b   Boschero, Antonio Carlos ^a   Bosqueiro, José Roberto ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Dexamethasone; Insulin resistance; Insulin secretion; Parasympathetic nervous system

Indexed keywords

CARBACHOL; DEXAMETHASONE; GLUCOSE; INSULIN; MUSCARINIC M3 RECEPTOR; PHOSPHOLIPASE C BETA1; PROTEIN KINASE C ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; MALE; NONHUMAN; PANCREAS ISLET; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; VAGOTOMY;

ANIMALS; BLOOD GLUCOSE; CARBACHOL; DEXAMETHASONE; DRUG TOLERANCE; GLUCOCORTICOIDS; GLUCOSE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MALE; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; STOMACH; VAGOTOMY; VAGUS NERVE;

EID: 74449084713     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.11.008     Document Type: Article

References (48)

1. Barbera M., Fierabracci V., Novelli M., Bombara M., Masiello P., Bergamini E., et al. Dexamethasone-induced insulin resistance and pancreatic adaptive response in aging rats are not modified by oral vanadyl sulfate treatment. Eur. J. Endocrinol. 145 (2001) 799-806
2. Severino C., Brizzi P., Solinas A., Secchi G., Maioli M., and Tonolo G. Low-dose dexamethasone in the rat. A model to study insulin resistance. Am. J. Physiol. 283 (2002) 367-373
3. Nicod N., Giusti V., Besse C., and Tappy L. Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers. Obes. Res. 11 (2003) 625-631
4. Bonner-Weir S., Trent D.F., Zmachinski C.J., Clore E.T., and Weir G.C. Limited beta cell regeneration in a beta cell deficient rat model: studies with dexamethasone. Metabolism 9 (1981) 914-918
5. Novelli M., De Tata V., Bombara M., Lorenzini A., Masini M., Pollera M., et al. Insufficient adaptative capability of pancreatic endocrine function in dexamethasone-treated ageing rats. J. Endocrinol. 162 (1999) 425-432
6. Holness M.J., Smith N.D., Greenwood G.K., and Sugden M.C. Interactive influences of peroxissome proliferator-activated receptor α activation and glucocorticoids on pancreatic beta cell compensation in insulin resistance induced by dietary saturated fat in the rat. Diabetologia 48 (2005) 2062-2068
7. Larsson H., and Arhén B. Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39 (1996) 1099-1107
8. 2+: new insights into stimulus-secretion coupling. Diabetes 46 (1997) 1928-1938
9. Ahrén B., Taborsky Jr. G.J., and Porte Jr. D. Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia 29 (1986) 827-836
10. Arhén B. Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans. Diabetologia 5 (2008) 1018-1024
11. Rasmussen H., Zawalich K.C., Ganesan S., Calle R., and Zawalich W.S. Physiology and pathophysiology of insulin secretion. Diabetes Care 13 (1990) 655-666
12. Ahrén B. Autonomic regulation of islet hormone secretion implications for health disease. Diabetologia 43 (2000) 393-410
13. Gilon P., and Henquin J.C. Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr. Rev. 22 (2001) 565-604
14. Miller R.E. Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the islets of Langerhans. Endocr. Rev. 2 (1981) 471-494
15. Ahrén B., and Lundquist I. Modulation of basal insulin secretion in the obese hyperglycemic mouse. Metabolism 31 (1982) 172-179
16. Shino A., Matsuo T., Iwatsuka I., and Suzuoki Z. Estructural changes of pancreatic islets in genetically obese rats. Diabetologia 9 (1973) 413-421
17. Rohner-Jeanrenaud F., Hochstrasser A.C., and Jeanrenaud B. Hiperinsulinemia of preobese and obese fa/fa rats is partly vagus nerve mediated. Am. J. Physiol. 244 (1983) 317-322
18. Edvell A., and Lindström P. Vagotomy in young obese hyperglycemic mice: effects on syndrome development and islet proliferation. Am. J. Physiol. 274 (1998) 1034-1039
19. Saad M.J., Folli F., Kahn J.A., and Kahn C.R. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J. Clin. Invest. 92 (1993) 2065-2072
20. Rafacho A., Giozzet V.A.G., Boschero A.C., and Bosqueiro J.R. Functional alterations in endocrine pancreas of rats with different degrees of dexamethasone-induced insulin resistance. Pancreas 6 (2008) 284-293
21. Burén J., Liu H.X., Jensen J., and Eriksson J.W. Dexamethasone impairs insulin signaling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocyte. Eur. J. Endocrinol. 146 (2002) 419-429
22. Hoogwerf B., and Danese R.D. Drug selection and the management of corticosteroid-related diabetes mellitus. Rheum. Dis. Clin. North Am. 25 (1999) 489-505
23. Bernal-Mizrachi C., Xiaozhong L., Yin L., Knutsen H.R., Howard J.M., Arends J.J., et al. An afferent vagal nerve pathway links hepatic PPARα activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metabol. 5 (2007) 91-102
24. Dixon K.D., Williams F.E., Wiggins R.L., Pavelka J., Lucente J., Bellinger L.L., et al. Differential effects of selective vagotomy and tropisetron in aminoprivic feeding. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 (2000) 997-1009
25. Bernstein I.L., and Goehler L.E. Vagotomy produces learned food aversions in the rat. Behav. Neurosci. 97 (1983) 585-594
26. Campfield L.A., Smith F.J., and LeMagnen J. Altered endocrine pancreatic function following vagotomy: possible behavioral and metabolic bases for assessing completeness of vagotomy. J. Auton. Nerv. Syst. 9 (1983) 283-300
27. Rafacho A., Roma L.P., Taboga S.R., Boschero A.C., and Bosqueiro J.R. Dexamethasone induced insulin resistance is associate with increase of connexin 36 mRNA and protein expression in pancreatic rat islets. Can. J. Physiol. Pharmacol. 85 (2007) 881-885
28. Scott A.M., Atwater I., and Rojas E. A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans. Diabetologia 21 (1981) 470-475
29. Boschero A.C., Szpak-Glasmam M., Carneiro E.M., Bordin S., Paul I., Rojas E., et al. Oxometrine-m potentiation of glucose-induced insulin release from rat islets involves M3 muscarinic receptors. Am. J. Physiol. 268 (1995) 336-442
30. Rafacho A., Ribeiro D.L., Boschero A.C., Taboga S.R., and Bosqueiro J.R. Increased pancreatic islet mass is accompanied by activation of the IRS-2/AKT pathway and augmented cyclin D2 protein levels in insulin resistant rats. Int. J. Exp. Pathol. 89 (2008) 264-275
31. Larsson H., and Ahrén B. Insulin resistant subjects lack islet adaptation to acute dexamethasone-induced reduction in insulin sensitivity. Diabetologia 42 (1999) 936-943
32. Rafacho A., Cestari T.M., Taboga S.R., Boschero A.C., and Bosqueiro J.R. High doses of dexamethasone induce increased beta-cell proliferation in pancreatic rat islets. Am. J. Physiol. Endocrinol. Metab. 296 (2009) 681-690
33. Xie H., Tsybenko V.A., Johnson M.V., and Lautt W.W. Insulin resistance of glucose response produced by hepatic denervations. Can. J. Physiol. Pharmacol. 1 (1993) 175-178
34. Cusin I., Rouru J., and Rohner-Jeanrenaud F. Intracerebroventricular glucocorticoid infusion in normal rats: induction of parasympathetic-mediated obesity and insulin resistance. Obes. Res. 9 (2001) 401-406
35. Guillaume G.C., Assimacopoulos J.F., and Jeanrenaud B. Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats. Diabetologia 36 (1993) 899-906
36. Mitrani P., Srinivasan M., Dodds C., and Patel M.S. Autonomic involvement in the permanent metabolic programming of hyperinsulinemia in the high-carbohydrate rat model. Am. J. Physiol. Endocrinol. Metab. 292 (2007) 1364-1377
37. Xue C., Aspelund G., Sritharan K.C., Wang J.P., Slezak L.A., and Andersen D.K. Isolated hepatic cholinergic denervation impairs glucose and glycogen metabolism. J. Surg. Res. 90 (2000) 19-25
38. Rafacho A, Marroquí L, Taboga SR, Abrantes JLF, Silveira LR, Boschero AC, et al. Glucocorticoids in vivo induce both insulin hypersecretion and enhanced glucose sensitivity of stimulus-secretion coupling in isolated rat islets. Endocrinology 151 (2010); in press.
39. Balkan B., and Dunning B.E. Muscarinic stimulation maintains in vivo insulin secretion in response to glucose after prolonged hyperglycemia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 268 (1995) 475-479
40. Ilcol Y.O., Gurun M.S., Taga Y., and Ulus I.H. Intraperitoneal administration of choline increases serum glucose in rat: involvement of the sympathoadrenal system. Horm. Metab. Res. 34 (2002) 341-347
41. Ilcol Y.O., Gurun M.S., Taga Y., and Ulus I.H. Choline increases serum insulin in rat when injected intraperitoneally and augments basal and stimulated aceylcholine release from the rat minced pancreas in vitro. Eur. J. Biochem. 270 (2003) 991-999
42. Ilcol Y.O., Yilmaz Z., and Ulus I.H. Serum free and phospholipid-bound choline decrease after surgery and methylprednisolone administration in dogs. Neurosci. Lett. 339 (2003) 195-198
43. Verspohl E.J., and Herrmann K. Involvement of G proteins in the effect of carbachol and cholecystokinin in rat pancreatic islets. Am. J. Physiol. 271 (1996) 65-72
44. Ahrén B., Karlsson S., and Lindskog S. Cholinergic regulation of the endocrine pancreas. Prog. Brain Res. 84 (1990) 209-218
45. Persaud S.J., Jones P.M., and Howell S.J. Activation of protein kinase C is essential for sustained insulin secretion in response to cholinergic stimulation. Biochim. Biophys. Acta 1091 (1991) 120-122
46. Niwa T., Matsukawa Y., Senda T., Nimura Y., Hidaka H., and Niki I. Acetylcholine activates intracellular movement of insulin granules in pancreatic beta-cells via inositol triphosphate-dependent mobilization of intracellular Ca2+. Diabetes 47 (1998) 1699-1706
47. Jarhult J., Ahrén B., Erichsen C., and Lundquist I. Improved insulin release to carbachol after vagotomy in rats-an effect due to cholinergic supersensitivity of the β-cells?. Acta Physiol. Scand. 118 (1983) 87-89
48. Ostenson C.G., and Grill V. Evidence that hyperglycemia increases muscarinic binding in pancreatic islets of the rat. Endocrinology 121 (1987) 1705-1710